“…Ordinary, m1 and m3 are located in the 3' noncoding region, giving rise to a MspI restriction site; whereas m2 and m4 are located in exon 7, leading to the amino acid transition of isoleucine to valine on codon 462 and threonine to asparagine on codon 461, respectively (Li et al, 2004). To date, genetic polymorphisms of human CYP1A1 have been widely studied for the susceptibility to various cancers (e.g., cancer of lung, oral, larynx, breast, thyroid, prostate, renal, cervix uteri, gastric, and colon) (Li et al, 2004;Gajecka et al, 2005;Little et al, 2006;Siraj et al, 2008;Wright et al, 2010;Li et al, 2016;Balaji et al, 2012;Agudo et al, 2014;Meng et al, 2015). Notwithstanding, to our knowledge there are no recent reports of any association between the four polymorphic loci of the CYP1A1 and cervical cancer susceptibility (Sugawara et al, 2003;Juárez-Cedillo et al, 2007;Gutman et al, 2009;Roszak et al, 2014;Abbas et al, 2014;Tan et al, 2016;Jain et al, 2017).…”